For example, GC patients with p16INK4a methylation were reported to specifically benefit from 5-FU adjuvant chemotherapy [6], and methylation of PYCARD and DAPK1, the apoptosis-related genes, resulted in resistance to 5-FU and poor prognoses in GC patients [7]. The gene discussed is CDKN2A; the disease is gastric cancer.